Spanish Red Biotech Pipeline

Peptomyc

OMO-103

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: First pan-MYC inhibitor in the clinic
Phase: 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical